Language:
en 
العربية
বাংলা
Cebuano
简体中文
繁體中文
Dansk
Nederlands
Eesti
Suomi
Français
Deutsch
Ελληνικά
עִבְרִית
हिन्दी
Íslenska
Bahasa Indonesia
Italiano
日本語
한국어
Latviešu valoda
Lietuvių kalba
Bahasa Melayu
Norsk bokmål
Polski
Português
Română
Español
Kiswahili
Svenska
தமிழ்
Türkçe
Українська
Tiếng Việt
Zulu
Daily summary of financings for therapeutic biotechnology company executives and investors
Friday, April 4, 2025
CytoSorbents’s $5 Million Series B Warrants
Thursday, April 3, 2025
Blackstone’s $3.1 Billion Acquisition of Anthos
MoonLake’s $500 Million Debt Financing
Neurona’s $102 Million Venture Financing
Ernexa’s $69 Million Private Placement
Aptevo’s $2 Million Registered Direct Offering
Wednesday, April 2, 2025
Edgewise’s $200 Million Public Offering
Atsena’s $150 Million Series C…More
GRI Bio’s $5 Million Public Offering
Concentra’s Acquisition of Allakos…More
Tuesday, April 1, 2025
J&J’s $0.7 Billion Acquisition of Intra-Cellular
AIRNA’s $155 Million Series B…More
GRI’s $5 Million Public Offering
Citius’s $2 Million Registered Direct Offering
Qualigen’s Acquisition of Marizyme
Monday, March 31, 2025
NLS’s $30 Million Equity Investment
Polyrizon’s $17 Million Private Placement
Marvel’s $1 Million Private Placement
Ensysce’s $1 Million Registered Direct Offering
Friday, March 28, 2025
DBV’s $307 Million Warrant Exercise
Eagle’s $69 Million Royalty Financing
Dermata’s $6 Million Warrant Exercise
Calidi’s $4 Million Registered Direct Offering
Thursday, March 27, 2025
Tribune’s $39 Million Series A
Galatea’s $25 Million Venture Financing
NeuroNOS’s $2 Million Equity Investment
Cyclacel’s $1 Million Private Placement
MaaT’s $14 Million Private Placement
Vivani’s $9 Million Private Placement
Wednesday, March 26, 2025
Savara’s $200 Million Debt Financing
Callio’s $187 Million Series A
Supira’s $120 Million Series E
Epicrispr’s $68 Million Series B
Tuesday, March 25, 2025
Character’s $93 Million Series B…More
Hillstar’s $67 Million Series A
Benitec’s $30 Million Public Offering
Genelux’s $11 Million Public Offering
Owlstone’s $2 Million Equity Investment
Monday, March 24, 2025
Surrozen’s $175 Million Private Placement
Sponsors
In coordination with an executive placement firm that is independent and unaffiliated with Collabrity, Inc., we may coordinate with executive(s) who are sourced by that firm and also independent and unaffiliated with Collabrity, Inc.: “Collabrity Executive(s)” does not imply an employment or independent contractor relationship with Collabrity, Inc.
Securities offered through Finalis Securities LLC Member FINRA / SIPC. Collabrity Inc. is not a registered broker-dealer, and Finalis Securities LLC and Collabrity Inc. are separate, unaffiliated entities. Finalis Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck